The spectrum of giant cell arteritis through a rheumatology lens
MI Khalique, M Arjunan, S Wood, SL Mackie - Eye, 2024 - nature.com
Abstract Treatment of giant cell arteritis (GCA) aims initially to prevent acute visual loss, and
subsequently to optimise long-term quality of life. Initial prevention of acute visual loss in …
subsequently to optimise long-term quality of life. Initial prevention of acute visual loss in …
Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study
N Mensch, AK Hemmig, M Aschwanden, S Imfeld… - RMD open, 2023 - rmdopen.bmj.com
Objectives We evaluated the feasibility of a rapid glucocorticoid tapering regimen to reduce
glucocorticoid exposure in patients with giant cell arteritis (GCA) treated with glucocorticoids …
glucocorticoid exposure in patients with giant cell arteritis (GCA) treated with glucocorticoids …
Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: a retrospective cohort study
L Moreel, A Betrains, L Boeckxstaens… - Seminars in Arthritis and …, 2024 - Elsevier
Objectives To evaluate differences in presentation and outcome of giant cell arteritis (GCA)
patients with and without polymyalgia rheumatica (PMR) symptoms. Methods Consecutive …
patients with and without polymyalgia rheumatica (PMR) symptoms. Methods Consecutive …
Comparing Diagnostic Performance of Short and Long [18F]FDG-PET Acquisition Times in Giant Cell Arteritis
PH Nienhuis, M van Nieuwland, GD van Praagh… - Diagnostics, 2023 - mdpi.com
(1) Background: In giant cell arteritis (GCA), the assessment of cranial arteries using [18F]
fluorodeoxyglucose ([18F] FDG) positron emission tomography (PET) combined with low …
fluorodeoxyglucose ([18F] FDG) positron emission tomography (PET) combined with low …
Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis
AK Hemmig, M Aschwanden, CT Berger… - …, 2024 - academic.oup.com
Objectives To investigate the hypothesis that a history of PMR is associated with a more
severe and damaging disease course in newly diagnosed GCA patients. Methods This was …
severe and damaging disease course in newly diagnosed GCA patients. Methods This was …
Pseudopolyarthrite rhizomélique et artérite gigantocellulaire: incidence, prévalence, évolution dans le temps et aspects médico-économiques
JH Salmon, B Fautrel, V Devauchelle-Pensec… - Revue du …, 2024 - Elsevier
Polymyalgia rheumatica is mainly manifested by inflammatory pains of the belts after 50
years. It may or may not be associated with giant cell arteritis that may present as a cranial or …
years. It may or may not be associated with giant cell arteritis that may present as a cranial or …
[HTML][HTML] An atypical presentation of giant cell arteritis: Fatigable signs to anterior ischemic optic neuropathy and choroidal infarction
M Shinbashi, S Hakim, E Mechel, MC Mehta… - Clinical Case …, 2023 - ncbi.nlm.nih.gov
Giant cell arteritis (GCA) is a vision‐threatening, ophthalmic emergency that classically
presents with new‐onset headaches, scalp tenderness, systemic symptoms, visual …
presents with new‐onset headaches, scalp tenderness, systemic symptoms, visual …